[1] |
LI Min, WANG Shanshan, LIU Zhonghe, JIANG Deguo.
Expression and mechanism of p38MAPK signaling pathway in chronic pulpitis rats with pain
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(6): 644-649.
|
[2] |
HUANG Lijia, HUANG Yang, KONG Jinsong, ZHENG Xin, GONG Xiaokang, RUAN Jianwei, WANG Haibao.
Inhibition of articular cartilage degeneration by atorvastatin calcium via STAT1-caspase-3 signaling axis in rats with knee osteoarthritis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(7): 743-748.
|
[3] |
LI Fang, ZHENG Liupu, WENG Jianlong, GUO Tao, SONG Xingwei, ZHENG Rongyuan.
Therapeutic time window of effectiveness for idazoxan ameliorating brain damage of rats with experimental autoimmune encephalomyelitis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(1): 1-7.
|
[4] |
SHI Liu-xia, JIN Yue-long, WANG Xiang-yu, HE Lian-ping, YAO Ying-shui.
The expression of high sensitive C-reactive protein and inflammation cytokines in periodontitis patients with hypertension and type 2 diabetes mellitus
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(5): 541-545.
|
[5] |
LI Pan, ZHAO Yi-bo, LI Xiao-li, LI Bin, ZHOU Hong.
The sensitivity of LPS tolerance mice to Escherichia coli is mediated through modulation of pro-inflammatory cytokine release
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(3): 261-265.
|
[6] |
LIN Jia, LIU Guang-nan, PAN Jing-qiang, KUANG Shao-song, HUANG Xiao-qiong, RAO Zi-liang.
Effects of bromocriptine, rosiglitazone and metformin on insulin resistance downregulating proinflammatory cytokines and metabolism of lipids in rats with polycystic ovary syndrome
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(4): 391-396.
|
[7] |
SHANG Fu-jun, WANG Jie-pin, ZHENG Qiang-sun, LIU Xiong-tao, XUE Yu-sheng, HE Yong, ZHANG Lu-xing, LIU Hui, WANG Bin, ZHAO Lian-you.
Simvastatin inhibit the expression of tumor necrosis factor-αin rat cadiocyte and the relation with reactive oxygen species
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(12): 1379-1385.
|
[8] |
ZHANG Dao-you, YANG Yan-lang, YANG Li-cai, XU Hai-hong, WANG Yu-wei.
Clinical investigation of the correlation between TNF-αand proteinuria in patients with chronic glomerulonephritis treated with angiotensin Ⅱ blockers
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(3): 332-335.
|
[9] |
WANG Jun, ZHOU Hong.
Protective effects of artemisinin challenged with CpG DNA in mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(3): 290-293.
|
[10] |
LIU Hong, YU Ji-Rong, LIU Bi-Cheng, WANG Yan-Li, YIN Lian-Fang, ZHANG Xiao-Liang.
Influence of irbesartan on blood pressure and proteinuria in patients with chronic glomerulonephritis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(1): 95-97.
|
[11] |
SUN Xue-Feng, ZHOU Xi-Jing, WANG Li-Ning.
Effects of enalapril in patients of chronic glomerulonephritis with severe renal failure
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2001, 6(4): 356-360.
|
[12] |
Zhang Daoyou, Ye Rengao1, Lu Zhi, Yang Weiming.
Arterial Hypertension and its Influence on Renal Function in Chronic Glomerulonephritis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 1996, 1(2): 102-106.
|